4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001770390-26-000002
Chief Scientific Officer gave up 5,098 shares (to pay taxes)
- Chief Scientific Officer acquired 12,376 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Humeau Laurent Chief Scientific Officer | 2026-02-26 | Option exercise | +5,010 | 37,632 | D: show line 1 in the form | ||
| Humeau Laurent Chief Scientific Officer | 2026-02-26 | Shares withheld for taxes | −2,064 | $1.79 | $3,695 | 35,568 | D: show line 2 in the form |
| Humeau Laurent Chief Scientific Officer | 2026-02-26 | Option exercise | +7,366 | 42,934 | D: show line 3 in the form | ||
| Humeau Laurent Chief Scientific Officer | 2026-02-26 | Shares withheld for taxes | −3,034 | $1.79 | $5,431 | 39,900 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Humeau Laurent Chief Scientific Officer | 2026-02-26 | Option exercise · Restricted Stock Unit | −5,010 | 5,009 | D: show line 5 in the form | |||||
| Humeau Laurent Chief Scientific Officer | 2026-02-26 | Option exercise · Restricted Stock Unit | −7,366 | 14,732 | D: show line 6 in the form |
Loading xslF345X05/wk-form4_1772228940.xml…